Fenimore Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.94M Hold
7,425
– – 0.04% 79
2026
Q2
$1.87M Hold
7,425
– – 0.04% 77
2026
Q1
$1.61M Sell
7,425
-23
-0.3% -$5.1K 0.04% 73
2025
Q4
$1.7M Sell
7,448
-5
-0.1% -$1.14K 0.04% 74
2025
Q3
$1.73M Hold
7,453
– – 0.03% 74
2025
Q2
$1.38M Hold
7,453
– – 0.03% 76
2025
Q1
$1.56M Sell
7,453
-28
-0.4% -$5.44K 0.03% 78
2024
Q4
$1.33M Sell
7,481
-27
-0.4% -$4.96K 0.03% 78
2024
Q3
$1.48M Buy
7,508
+27
+0.4% +$5.04K 0.03% 80
2024
Q2
$1.28M Hold
7,481
– – 0.03% 79
2024
Q1
$1.36M Sell
7,481
-29
-0.4% -$5K 0.03% 77
2023
Q4
$1.16M Sell
7,510
-8
-0.1% -$1.17K 0.03% 79
2023
Q3
$1.12M Hold
7,518
– – 0.03% 78
2023
Q2
$1.01M Hold
7,518
– – 0.03% 81
2023
Q1
$1.2M Sell
7,518
-300
-4% -$45.9K 0.03% 77
2022
Q4
$1.26M Hold
7,818
– – 0.03% 83
2022
Q3
$1.05M Hold
7,818
– – 0.03% 83
2022
Q2
$1.2M Sell
7,818
-57
-0.7% -$8.71K 0.03% 84
2022
Q1
$1.28M Hold
7,875
– – 0.03% 84
2021
Q4
$1.07M Hold
7,875
– – 0.02% 87
2021
Q3
$849K Hold
7,875
– – 0.02% 87
2021
Q2
$887K Hold
7,875
– – 0.02% 89
2021
Q1
$852K Sell
7,875
-100
-1% -$10.7K 0.02% 87
2020
Q4
$855K Hold
7,975
– – 0.02% 82
2020
Q3
$699K Hold
7,975
– – 0.02% 83
2020
Q2
$783K Buy
+7,975
New +$702K 0.03% 83

Other funds holding ABBV

Fenimore Asset Management's ABBV Position: Q3 2026 in Review

Fenimore Asset Management held its AbbVie (ABBV) position steady in Q3 2026 at 7,425 shares worth $1.94M. The position accounts for 0.04% of the portfolio, ranked #79.

Fenimore Asset Management first reported a position in ABBV in Q2 2020 and has held it in 26 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Fenimore Asset Management held 7,425 shares of AbbVie worth $1.94M as of Q3 2026.
  • Fenimore Asset Management left its AbbVie share count unchanged in Q3 2026.
  • AbbVie made up 0.04% of Fenimore Asset Management's portfolio in Q3 2026, its #79 holding.
  • Fenimore Asset Management first reported a position in AbbVie in Q2 2020 and has held it in 26 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Fenimore Asset Management's 13F filing for Q3 2026, filed 8 Oct 2026.